DHG Pharmaceutical JSC (HOSE:DHG)

Vietnam flag Vietnam · Delayed Price · Currency is VND
103,300
-1,300 (-1.24%)
At close: Mar 2, 2026
1.97%
Market Cap 13.51T
Revenue (ttm) 4.98T
Net Income (ttm) 891.34B
Shares Out 130.75M
EPS (ttm) 6,816.87
PE Ratio 15.15
Forward PE 13.34
Dividend 10,000.00 (9.56%)
Ex-Dividend Date n/a
Volume 12,428
Average Volume 13,828
Open 104,900
Previous Close 104,600
Day's Range 103,100 - 104,900
52-Week Range 87,000 - 110,700
Beta 0.41
RSI 59.20
Earnings Date Apr 17, 2026

About DHG Pharmaceutical JSC

DHG Pharmaceutical Joint Stock Company, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products in Vietnam. The company offers antibiotic, analgesic and antipyretic, respiratory, nutrition, musculoskeletal, gastrointestinal and hepatobiliary, nervous and ophthalmic, cardiovascular and diabetic, and dermatology and beauty care products. It also manufactures and trades in health food, dietary and consumer health supplements, and pharmaceuticals cosmetic products. It also exports its products. DHG Pharmaceuti... [Read more]

Industry Pharmaceutical Preparations
Founded 1974
Employees 2,819
Stock Exchange Ho Chi Minh Stock Exchange
Ticker Symbol DHG
Full Company Profile

Financial Performance

In 2024, DHG Pharmaceutical JSC's revenue was 4.88 trillion, a decrease of -2.60% compared to the previous year's 5.02 trillion. Earnings were 753.55 billion, a decrease of -25.91%.

Financial Statements

News

There is no news available yet.